OraSure takes off after earnings beat, guidance

OraSure (OSUR +16.1%) is among the day's big winners after the company reported a Q2 loss that was narrower than analysts expected.

Revenue growth of 8% for the period was attributable to strong sales of OSUR's "molecular collection systems and infectious disease testing products."

OSUR guided for a Q3 net loss of $0.09-0.10/ share versus Street estimates of a $0.12 loss. Revenue guidance is in line with consensus. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs